First-line chemotherapy of docetaxel/cisplatin for unresectable non-small cell lung cancer

作者
Jie Zhang
出处
期刊:Chinese clinical oncology [AME Publishing Company]
摘要

Objective:To investigate effects and safety of docetaxel/cisplatin given as first-line chemotherapy every 4 weeks in unresectable non-small cell lung cancer (NSCLC). Methods:Thirty-nine patients (male/female: 21/18) with unresectable NSCLC were enrolled for the study. They were at the ages ranging from 33 to 79 years old with ECOG PS of 0~2. Docetaxel and cisplatin were administered at the dose of 75 mg/m 2 on day 1 intravenously every 4 weeks. The responses and toxicity of chemotherapy were evaluated every two cycles and survival was followed up.Results:In the 38 evaluable cases, partial response (PR) and complete response (CR) were observed in 21 cases and 1 case, respectively with overall response rate of 58%. The response rate in the cases with ECOG PS of 0~1 was significantly higher than in those with ECOG PS of 2. Median survival time was 14 months and 1 year-survival rate was 61 5%. The toxicities were mild, including 40% Grade 3 or 4 leucopenia. One case died from leucopenia infection soon after 1 cycle of chemotherapy. Conclusion:Four-week regimen of docetaxel/cisplatin was effective and safe as the first line treatment for the unresectable NSCLC patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
111完成签到 ,获得积分10
1秒前
dph完成签到 ,获得积分10
1秒前
2秒前
糖糖糖完成签到 ,获得积分10
2秒前
爱喝绿茶的皮卡丘完成签到,获得积分10
2秒前
动听紫夏完成签到,获得积分10
3秒前
4秒前
彭于晏的应助被zyy采纳,获得30
5秒前
5秒前
惠1发布了新的文献求助10
6秒前
gerrard完成签到,获得积分10
6秒前
小马甲的应助被孟yifan采纳,获得10
6秒前
6秒前
lukaku完成签到,获得积分10
6秒前
7秒前
可耐的思枫完成签到,获得积分10
7秒前
7秒前
7秒前
乐乐的应助被乐乐1314采纳,获得10
8秒前
繁荣的雨南完成签到,获得积分10
9秒前
djdj放技能完成签到 ,获得积分10
9秒前
9秒前
111发布了新的文献求助10
10秒前
10秒前
忐忑的火龙果完成签到,获得积分10
10秒前
fjmelite完成签到 ,获得积分10
10秒前
廾匸发布了新的文献求助10
11秒前
科研通AI6.4的应助被zyy采纳,获得10
11秒前
伊地知虹夏完成签到,获得积分10
11秒前
韩冬完成签到,获得积分10
12秒前
13秒前
乐乐的应助被快乐冷荷采纳,获得10
15秒前
阔达的皮皮虾完成签到,获得积分10
16秒前
16秒前
丘比特的应助被健忘的奇异果采纳,获得10
16秒前
Owen的应助被2711采纳,获得10
17秒前
CipherSage的应助被黑粉头头采纳,获得10
17秒前
18秒前
搜集达人的应助被Luo采纳,获得10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187362
求助须知:如何正确求助?哪些是违规求助? 9575478
关于积分的说明 21841431
捐赠科研通 7785067
什么是DOI,文献DOI怎么找? 3434943
关于科研通互助平台的介绍 2559401
邀请新用户注册赠送积分活动 2481820